ARDX Quote, Trading Chart, Ardelyx Inc.

$0.6574 Last:

6.88% Change Percent:

$0.64 Open:

$0.6574 Previous Close:

$0.6679 High:

$0.6 Low:

1,629,477 Volume:

05/27/2022 04:53:25 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2022-05-27	0.64	0.6574	0.6679	0.6	1,629,477
2022-05-26	0.6056	0.6151	0.647	0.6006	2,331,140
2022-05-25	0.6155	0.6054	0.62	0.591	1,110,990
2022-05-24	0.63	0.595	0.6438	0.5812	2,019,557
2022-05-23	0.655	0.63	0.66	0.6235	1,228,745
2022-05-20	0.6765	0.6532	0.69	0.62	1,431,934
2022-05-19	0.6751	0.675	0.6994	0.655	2,023,093
2022-05-18	0.6832	0.6578	0.6999	0.6552	1,637,948
2022-05-17	0.6601	0.694	0.6999	0.65	1,674,419
2022-05-16	0.6819	0.6461	0.6899	0.6401	1,945,388
2022-05-13	0.675	0.6531	0.6991	0.6401	2,094,964
2022-05-12	0.5939	0.6438	0.6665	0.59	2,200,454
2022-05-11	0.7	0.58	0.7018	0.577	3,788,388
2022-05-10	0.72	0.7234	0.765	0.7	1,654,146
2022-05-09	0.7977	0.7162	0.7977	0.7101	2,526,114
2022-05-06	0.8026	0.8101	0.8158	0.761	3,243,392
2022-05-05	0.94	0.8375	0.94	0.81	2,153,482
2022-05-04	0.9	0.9073	0.9397	0.8534	2,520,614
2022-05-03	0.83	0.891	0.9014	0.83	3,196,165
2022-05-02	0.8	0.8382	0.8498	0.7827	2,087,320

Stock Information

Ardelyx Inc. Company Name:

ARDX Stock Symbol:

NASDAQ Market:

Ardelyx Inc. Website:

ARDX Quote, Trading Chart, Ardelyx Inc.

Get ARDX Alerts

News, Short Squeeze, Breakout and More Instantly...

ARDX - Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults PR Newswire Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable...
ARDX - Which Penny Stocks Are Investors Buying Right Now? 3 to Watch

3 Penny Stocks That Investors Are Buying in May 2022 With May proving to be another interesting month for penny stocks and blue chips, there is a lot that investors need to keep track of. First and foremost, we know that penny stocks are in an extremely volatile place right now. Thi...
ARDX - Ardelyx Announces Additional Data Supporting the Efficacy and Safety of First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at DDW 2022

Ardelyx Announces Additional Data Supporting the Efficacy and Safety of First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at DDW 2022 PR Newswire WALTHAM, Mass. , May 17, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharma...